Antigen-specific cytokine and antibody isotype profiles induced by mucosal and systemic immunization with recombinant adenoviruses

Viral Immunology

Volumn 12, Issue 2, 1999, Pages 107-116

  Papp, Zsuzsanna ^a   Babiuk, Lorne A ^a   Baca Estrada, Maria E ^a,b  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN A; INTERLEUKIN 4; VIRUS GLYCOPROTEIN; VIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIGEN SPECIFICITY; ARTICLE; BOVINE HERPES VIRUS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN ADENOVIRUS 5; IMMUNIZATION; INTRANASAL DRUG ADMINISTRATION; LUNG LAVAGE; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; RESPIRATORY TRACT INFECTION; SUBCUTANEOUS DRUG ADMINISTRATION; T LYMPHOCYTE; VIRUS INFECTION; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALIA; BOVINAE; BOVINE HERPESVIRUS 1; DNA VIRUSES; HERPES; HERPESVIRIDAE; HUMAN ADENOVIRUS; HUMAN ADENOVIRUS TYPE 5;

EID: 0032994188     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.1999.12.107     Document Type: Article

References (24)

1. Baca-Estrada, M.E., M. Snider, S.K. Tikoo, R. Harland, L.A. Babiuk, and S. van Drunen Littel-van den Hurk. 1996. Immunogenicity of bovine herpesvirus 1 glycoprotein D in mice: effect of antigen form on the induction of cellular and humoral immune responses. Viral Immunol. 9:11-22.
2. Baca-Estrada, M.E., M. Foldvari, M. Snider, S. van Drunen Littel-van den Hurk, and L.A. Babiuk. 1997. Effect of IL-4 and IL-12 liposomal formulations on the induction of immune response to bovine herpesvirus type-1 glycoprotein D. Vaccine. 15:1753-1760.
3. Bachmann, M.F., and R.M. Zinkemagel. 1996. The influence of virus structure on antibody responses and virus serotype formation. Immunol. Today. 17:553-558.
4. Blair, E.G., S.C. Dixon, S.A. Griffiths, and M.E. Blair Zajdel. 1989. Restricted replication of human adenovirus type 5 in mouse cells. Virus Res. 14:339-346.
5. Both, G.W., L.J. Lockett, V. Janardhana, S.J. Edwards, A.R. Bellamy, F.L. Graham, and L. Prevec. 1993. Protective immunity to rotavirus-induced diarrhoea is passively transferred to newborn mice from naive dams vaccinated with a single-dose of a recombinant adenovirus expressing rotavirus VP7sc. Virology 193:940-950.
6. D'Orazio, T.J., and J.Y. Niederkorn. 1998. The nature of antigen in the eye has a profound effect on the cytokine milieu and resultant immune response. Eur. J. Immunol. 28:1544-1553.
7. Flanagan, B., C.R. Pringle, and K.N. Leppard. 1997. A recombinant human adenovirus expressing the simian immunodeficiency virus Gag antigen can induce long-lived immune responses in mice. J. Gen. Virol. 78:991-997.
8. Gallichan, W.S., D.C. Johnson, K.L. Graham, and K.L. Rosenthal. 1993. Mucosal immunity and protection after intranasal immunization with recombinant adenovirus expressing herpes simplex virus glycoprotein B. J. Infect. Dis. 168:622-629.
9. Ginsberg, H.S., L.L. Moldawer, S.B. Pravinkumar, M. Redington, P.L. Kilian, R.M. Chanock, and G.A. Prince. 1991. A mouse model for investigating the molecular pathogenesis of adenovirus pneumonia. Proc. Natl. Acad. Sci. USA. 88:1651-1655.
10. Gonin, P., W. Oualikene, A. Fournier, and M. Eloit. 1996. Comparison of the efficacy of replication-defective adenovirus and Nyvac poxvirus as vaccine vectors in mice. Vaccine. 14:1083-1087.
11. Graham, F.L., and L. Prevec. 1991. Manipulation of adenovirus vectors, pp 109-129. In E.J. Murray, ed. Methods in molecular biology, vol. 7. Gene transfer and expression protocols. Humana Press, Clifton, NJ.
12. Imler, J.-L. 1995. Adenovirus vectors as recombinant viral vaccines. Vaccine 13:1143-1151.
13. Kowalski, J., S.A. Gilbert, S. van Drunen Littel-van den Hurk, J. van den Hurk, L.A. Babiuk, and T.J. Zamb. 1993. Heat-shock promoter-driven synthesis of secreted bovine herpesvirus glycoproteins in transfected cells. Vaccine. 11:1100-1107.
14. Mittal, S.K., Z. Papp, S.K. Tikoo, M.E. Baca-Estrada, D. Yoo, M. Benko, and L.A. Babiuk. 1996. Induction of systemic and mucosal immune responses in cotton rats immunized with human adenovirus type 5 recombinants expressing the full and truncated forms of bovine herpesvirus type 1 glycoprotein gD. Virology 222:299-309.
15. Papp, Z., L.A. Babiuk, and M.E. Baca-Estrada. 1999. The effect of pre-existing adenovirus-specific immunity on immune responses induced by recombinant adenovirus expressing glycoprotein D of bovine herpesvirus type 1. Vaccine. 17:933-943.
16. Papp, Z., L.A. Babiuk, and M.E. Baca-Estrada. 1998. Induction of immunity in the respiratory tract and protection from bovine herpesvirus type 1 infection by different routes of immunization with recombinant adenovirus. Viral Immunol. 11:79-91.
17. Prevec, L., M. Schneider, K.L. Rosenthal, L.W. Belbeck, J.B. Derbyshire, and F.L. Graham. 1989. Use of human adenovirus-based vectors for antigen expression in animals. J. Gen. Virol. 70:429-434.
18. Rosenthal, K.L., K.F.T. Copeland, and W.S. Gallichan. 1996. Recombinant adenoviruses as vectors for mucosal immunity, pp 147-158. In H. Kiyono, P.L. Ogra, and J.R. McGhee, eds. Mucosal vaccines. Academic Press, San Diego.
19. Sangster, M.Y., X.Y. Mo, R. Sealy, and C, Coleclough. 1997. Matching antibody class with pathogen type and portal of entry. J. Immunol. 159:1893-1902.
20. Toellner, K.M., S.A. Luther, D.M. Sze, R.K. Choy, D.R. Taylor, I.C.M. MacLennan, and H. Acha-Orbea. 1998. T helper 1 (Th1) and Th2 characteristics start to develop during T cell priming and are associated with an immediate ability to induce immunoglobulin calass switching. J. Exp. Med. 187:1193-1204.
21. van Drunen Littel-van den Hurk, S., S.K. Tikoo, J.V. van den Hurk, L.A. Babiuk, and J. van Donkersgoed. 1997. Protective immunity in cattle following vaccination with conventional and marker bovine herpesvirus-1 (BHV-1) vaccines. Vaccine. 15:36-44.
22. van Ginkel, F.W., C. Liu, J.W. Simecka, J.-Y. Dong, T. Greenway, R.A. Frizzell, H. Kiyono, J.R. McGhee, and D.W. Pascual. 1995. Intratracheal gene delivery with adenoviral vector induces elevated systemic IgG and mucosal IgA antibodies to adenovirus and beta-galactosidase. Hum. Gene Ther. 6:895-903.
23. van Ginkel, F.W., J.R. McGhee, C. Liu, J.W. Simecka, M. Yamamoto, R.A. Frizzell, E.J. Soscher, H. Kiyono, and D.W. Pascual. 1997. Adenoviral gene delivery elicits distinct pulmonary-associated T helper cell responses to the vector and to its transgene. J. Immunol. 159:685-693.
24. Yang, X., S.G. Randall, T.R. Mosmann, and K.T. HayGlass. 1993. Chemically modified antigen preferentially elicits induction of Th1-like cytokine synthesis patterns in vivo. J. Exp. Med. 178:349-353.